-
Detailed Analysis Generate Full Report Add to Watchlist
Values as of: 2024-06-26
JDHIY:OTC- (USD)
COMMON STOCK | Medical Care Facilities |
Last Closing
USD 3.2004Change
0.00 (0.00)%Market Cap
USD 13.08BVolume
N/AVerdict
Verdict
Values as of: 2024-06-26
COMMON STOCK | Medical Care Facilities |
Last Closing
USD 3.2004Change
0.00 (0.00)%Market Cap
USD 13.08BVolume
N/AVerdict
Verdict
Currency: USD
Country : USA
Symbol | Name | Price(Change) | Market Cap |
---|---|---|---|
FSNUF | Fresenius SE & Co. KGaA |
N/A |
USD 17.32B |
FSNUY | Fresenius SE & Co KGaA ADR |
N/A |
USD 16.85B |
FMCQF | Fresenius Medical Care AG & Co.. |
N/A |
USD 13.85B |
BDULF | Bangkok Dusit Medical Services.. |
N/A |
USD 13.23B |
BDUUY | Bangkok Dusit Medical Services.. |
N/A |
USD 12.69B |
BDUUF | Bangkok Dusit Medical Services.. |
N/A |
USD 12.31B |
JDHIF | JD Health International Inc |
N/A |
USD 11.64B |
IHHHF | IHH Healthcare Berhad |
N/A |
USD 11.26B |
RMYHY | Ramsay Health Care Ltd ADR |
N/A |
USD 7.87B |
RMSYF | Ramsay Health Care Limited |
N/A |
USD 7.58B |
N/A
Market Performance vs. Industry/Classification (Medical Care Facilities) | Market Performance vs. Exchange | ||||||
Value | Sector Median | Percentile Rank | Grade | Market Median | Percentile Rank | Grade | |
YTD | |||||||
Capital Gain | -35.99% | 25% | F | 18% | F | ||
Dividend Return | N/A | N/A | N/A | N/A | N/A | ||
Total Return | -35.99% | 24% | F | 18% | F | ||
Trailing 12 Months | |||||||
Capital Gain | -51.36% | 27% | F | 21% | F | ||
Dividend Return | N/A | N/A | N/A | N/A | N/A | ||
Total Return | -51.36% | 27% | F | 21% | F | ||
Trailing 5 Years | |||||||
Capital Gain | N/A | N/A | N/A | N/A | N/A | ||
Dividend Return | N/A | N/A | N/A | N/A | N/A | ||
Total Return | N/A | N/A | N/A | N/A | N/A | ||
Average Annual (5 Year Horizon) | |||||||
Capital Gain | -14.00% | 36% | F | 18% | F | ||
Dividend Return | -14.00% | 36% | F | 17% | F | ||
Total Return | N/A | N/A | N/A | N/A | N/A | ||
Risk Return Profile | |||||||
Volatility (Standard Deviation) | 22.94% | 84% | B | 82% | B | ||
Risk Adjusted Return | -61.02% | 23% | F | 12% | F | ||
Market Capitalization | 13.08B | 94% | A | 92% | A |
Target Price Action | Rating Action | Analyst | Rating | Price | Date |
---|
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.
This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.
The company had positive total cash flow in the most recent four quarters.
The company had positive total free cash flow in the most recent four quarters.
This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.
This stock has shown top quartile revenue growth in the previous 5 years compared to its sector.
This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.
The company management has delivered below median return on assets in the most recent 4 quarters compared to its peers.
The company management has delivered below median return on invested capital in the most recent 4 quarters compared to its peers.
The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.
The stock is trading high compared to its peers on a price to earning basis and is above the sector median.
The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.
The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.